Dr John McMurray Explains the Heart Failure Benefits of Dapagliflozin in Diabetics and Non-Diabetics
In patients with heart failure, both with and without diabetes, dapagliflozin was shown to provide identical efficacy and possibly beneficial effects on the heart, said John McMurray, MD, FRCP, FESC, professor of medical cardiology in the Institute of Cardiovascular and Medical Sciences at the University of Glasgow.